AI Article Synopsis
- The study looked at the impact of professional continuous glucose monitoring (p-CGM) on A1C levels in patients with type 2 diabetes who weren’t using insulin.
- It included data from 15,481 patients, finding that those using p-CGM experienced a greater decrease in A1C levels compared to those who didn’t use it, regardless of any insulin use later on.
- The results suggest that p-CGM can be beneficial for improving glycemic control in type 2 diabetes patients using multiple noninsulin treatments over a 6-month period.
Article Abstract
This retrospective analysis examined the association between change in A1C and professional continuous glucose monitoring (p-CGM) use in patients with type 2 diabetes and poor glycemic control who were not using insulin. Data from 15,481 eligible patients (p-CGM users = 707 and p-CGM nonusers = 14,774) showed a greater decrease in A1C from baseline to the end of follow-up for p-CGM users, and differences favored p-CGM users regardless of whether they started insulin therapy during the follow-up period. These findings suggest that people with type 2 diabetes who have poor glycemic control using multiple noninsulin therapies may benefit from p-CGM, which can reduce A1C over a 6-month period compared with usual care.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338284 | PMC |
| http://dx.doi.org/10.2337/cd22-0080 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!